UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 3, 2016
OCEAN BIO-CHEM, INC.
(Exact name of registrant as specified in charter)
| Florida | 0-11102 | 59-1564329 | ||
| (State
or Other Jurisdiction of Incorporation) |
(Commission File Number) | (I.R.S.
Employer Identification No.) |
4041 S.W. 47 Avenue, Fort Lauderdale, Florida 33314
(Address of principal executive offices) (Zip Code)
(954) 587-6280
Registrant’s telephone number, including area code:
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.07. Submission of Matters to a Vote of Security Holders
Ocean Bio-Chem, Inc. (the “Company”) held its Annual Meeting of Shareholders on June 3, 2016. The proposals submitted by the Board of Directors to a vote of shareholders, and the final results of the vote on each proposal, are set forth below.
Proposal No. 1 — Election of Directors
The following nominees were elected by shareholders to serve on the Company’s Board of Directors until the next annual meeting of shareholders or until their respective successors have been duly elected and qualified. The voting results with respect to each nominee were as follows:
| Nominees | For | Withheld | Broker Non-Votes | |||||||||
| Jeffrey S. Barocas | 6,523,018 | 792,341 | 1,341,600 | |||||||||
| Sonia B. Beard | 7,304,187 | 11,172 | 1,341,600 | |||||||||
| Diana Mazuelos Conard | 7,304,187 | 11,172 | 1,341,600 | |||||||||
| Gregor M. Dornau | 6,523,337 | 792,022 | 1,341,600 | |||||||||
| Peter G. Dornau | 6,533,337 | 782,022 | 1,341,600 | |||||||||
| William W. Dudman | 6,523,337 | 792,022 | 1,341,600 | |||||||||
| James M. Kolisch | 6,523,337 | 792,022 | 1,341,600 | |||||||||
| John B. Turner | 7,304,086 | 11,273 | 1,341,600 | |||||||||
Proposal No. 2 — Ratification of the Appointment of Independent Registered Public Accounting Firm.
The shareholders ratified of the appointment of Goldstein Schechter Koch P.A. as the Company's independent registered public accounting firm for 2016. The voting results were as follows:
| For | Against | Abstain | Broker Non-Votes | |||
| 8,649,120 | 7,758 | 481 | 0 |
Proposal No. 3 — Advisory Vote on the Compensation of the Company’s Named Executive Officers
The shareholders approved, on an advisory basis, the compensation of the Company’s named executive officers. The voting results were as follows:
| For | Against | Abstain | Non Votes | |||
| 7,198,439 | 113,364 | 3,956 | 1,341,600 |
| 2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| OCEAN BIO-CHEM, INC. | ||
| Date: June 6, 2016 | By: | /s/ Jeffrey S. Barocas |
| Jeffrey S. Barocas | ||
| Chief Financial Officer | ||
3